Skip to main content
SpringerLink
Log in

Sertraline enhances the effects of cognitive-behavioral treatment on weight reduction of obese patients

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Serotonin reuptake inhibitors, such as dexfenfluramine, fluoxetine and fluvoxamine, have been proposed as therapeutical tools for the treatment of eating disorders and obesity. Sertraline, a SSRI used in the treatment of depression, interferes with eating behavior in animal models, but it has not been tested in obese humans. Aim of this study is the assessment of the effects of sertraline on eating attitudes and body weight in obese patients with and without mood disorders. A consecutive series of 65 obese out-patients aged 18–65 years, with a body mass index (BMI) >30 kg/m2, was treated for 6 months with sertraline 150 mg/day per os, in addition to a cognitive-behavioral treatment (CBT). A consecutive series of 60 obese patients with similar characteristics, who were treated with CBT only, were used as control group. A greater reduction of BMI (mean±SD) was observed in sertraline-treated patients when compared to controls (from 35.3±5.7 to 32.0±5.4 kg/m2 in sertraline-treated patients, from 37.1 ±7.0 to 36.0±7.1 kg/m2 in controls; 6.5±5.4% vs. 3.0±6.3%; p<0.01), while a similar change in eating attitudes (evaluated through the BITE questionnaire) was observed in both groups. Effects of sertraline on eating attitudes and body weight were similar in patients with and without mood disorders. In conclusion, sertraline, administered together with CBT, seems to be more effective in inducing weight loss in obese patients when compared with CBT alone, and therefore it could be a useful tool in the first months of CBT for severe obesity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Liebowitz S.F. Neurochemical-neuroendocrine systems in the brain controlling macronutrient intake and metabolism. Trends Neurosci., 15: 491, 1992.

    Article  Google Scholar 

  2. Bray G.A. Treatment of obesity: a nutrient balance/nutrient partition approach. Nutr. Rev. 49: 33, 1991.

    Article  PubMed  CAS  Google Scholar 

  3. Liebowitz S.F. Brain neurochemical systems controlling appetite and body weight gain. In: Rothwell N.Y., Stock M.J. (Eds.), Obesity and cachexia. Wiley, NewYork, 1991.

    Google Scholar 

  4. Hill A.J., Blundell J.E. Sensitivity of the appetite control system in obese subjects to nutritional and serotoninergic challenges. Int. J. Obes. 14: 219, 1990.

    PubMed  CAS  Google Scholar 

  5. Cooper S.J. Drugs interacting with 5-HT systems show promise for treatment of eating disorders. Trends Pharmacol. Sei. 10: 56, 1989.

    Article  CAS  Google Scholar 

  6. Blundell J.E. Serotonin and the biology of feeding. Am. J. Clin. Nutr. 55: 155s, 1992.

    PubMed  CAS  Google Scholar 

  7. Wurtman J., Wurtman R., Mark S., Tsay R., Gilbert W., Growdon J. D-Fenfluramine selectively suppresses carbohydrate snacking by obese subjects. Int. J. Eating Dis. 4: 88, 1990.

    Google Scholar 

  8. American Medical Association Drug Evaluation. American Medical Association, Chicago, 1992.

  9. Murdoch D., Mc Tavish D. Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder. Drugs 44: 605, 1992.

    Article  Google Scholar 

  10. Reimherr F.W., Chouinard C, Cohn C.K., Cole J.O., Hil T.M., La Pierre Y.D., Masco H.L., Mendes J. Antidepressant efficacy of sertraline: a double-blind, placebo and amitryptiline-controlled, multicentric comparison study in outpatients with major depression. J. Clin. Psychiatry 51 (12 suppl B): 18, 1990.

    PubMed  Google Scholar 

  11. Cohn C.K., Shrivastava R., Mendes J., Cohn J.B., Fabre LR, Claghorn J.L., Dessain EC, Hil T.M., Lautin A. Double-blind, multicenter comparison of sertraline and amitryptiline in elderly depressed patients. J. Clin. Psychiatry 51 (12 suppl B): 28, 1990.

    PubMed  Google Scholar 

  12. Thompson C, Martindale. J.J., Doogan D. Sertraline in the treatment of depression in primary care. Clin. Neuropharmacol. 15 (suppl 1): 83, 1992.

    Article  Google Scholar 

  13. Chouinard G., Goodmann W., Greist J., Jenike M., Rasmussen S., White K., Hackett E., Gaffney M., Bick PA. Result of a double-blind, placebo-controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. Scand. J. Prim. Health Care 26: 279, 1990.

    CAS  Google Scholar 

  14. Marcus M.D., Wing R.R., Ewing L, Kern E., McDermott B.S., Goodwing W. A double-blind, placebo-controlled trial of fluoxetine plus behaviour modification in the treatment of obese binge-eaters and non-binge-eaters. Am. J. Psychiatry 147: 876, 1990.

    PubMed  CAS  Google Scholar 

  15. Ayuso-Gutierrez J.L., Palazon M., Ayuso-Mateos J.L. Open trial of fluvoxamine in the treatment of bulimia nervosa. Int. J. Eating Dis. 15: 245, 1994.

    Article  CAS  Google Scholar 

  16. Lucki I., Kreider M.S., Simansky K.J. Reduction of feeding behaviour by the serotonin uptake inhibitor sertraline. Psychopharmacology 96: 289, 1988.

    Article  PubMed  CAS  Google Scholar 

  17. Koe B.K. Preclinical pharmacology of sertraline: a potent and specific inhibitor of serotonin reuptake. J. Clin. Psychiatry 51(12 suppl B): 13, 1990.

    PubMed  Google Scholar 

  18. Simansky K.J., Vaidya A.H. Behavioural mechanism for the anorectic action of the serotonin (5-HT) uptake inhibitor sertralin in rats: comparison with directly acting 5-HT agents. Smooth Muscle Res. 25: 953, 1990.

    CAS  Google Scholar 

  19. Nielsen J.A., Chapin D.S., Johnson J.L., Tgersen L.K. Sertraline, a serotonin-uptake inhibitor, reduces food intake and body weight in lean rats and obese mice. Am. J. Clin. Nutr. 55: 185, 1992.

    Google Scholar 

  20. Grignaschi G., Neill J.C., Petrini A., Garattini S., Samanin R. Feeding pattern studies suggest that d-fenfluramine and sertraline specifically enhance the state of satiety in rats. Eur. J. Pharmacol. 211: 137, 1992.

    Article  PubMed  CAS  Google Scholar 

  21. Marcus M.D., Wing R.R., Hopkins J. Psychopathology associated with bulimia, binge eating and obesity. Int. J. Eating Dis. 7: 177, 1988.

    Article  Google Scholar 

  22. Prather R.C., Williamson D.A. Obese binge eaters: affect, cognitions and response to behavioural weight control. J. Consult. Clin. Psychol. 56: 433, 1988.

    Article  Google Scholar 

  23. Yanovski Z.S., Nelson J., Dubbert B., Spitzer R. Association of Binge Eating Disorder and Psychiatric Comorbidity in Obese Subjects. Am. J. Psychiatry 150: 10, 1993.

    Google Scholar 

  24. Antony M., Johnson W., Carr-Nangle R.E., Abel J.L. Psychopathology Correlates of Binge Eating and Binge Eating Disorder. Compr. Psychiatry 35: 386, 1994.

    Article  PubMed  CAS  Google Scholar 

  25. Specker S., de Zwaan M., Raymond N., Mitchell J. Psychopathology in subgroups of obese women with and without Binge Eating Disorder. Compr. Psychiatry 35: 185, 1994.

    Article  PubMed  CAS  Google Scholar 

  26. Marcus M.D., Wing R.R., Ewing L, Kern E., Gooding W., McDermott M. Psychiatric disorders among obese binge eaters. Int. J. Eating Disorders 9: 69, 1990.

    Article  Google Scholar 

  27. Fitzgibbon M. L, Stolley M. R., Kirschenbaum D. S. Obese people who seek treatment have different characteristics than those who do not seek treatment. Health Psychol. 12: 342, 1993.

    Article  PubMed  CAS  Google Scholar 

  28. Garner D.M., Wooley S.C. Confronting the failure of behavioral and dietary treatments for obesity. Clinical Psychological Review 11: 729, 1991.

    Article  Google Scholar 

  29. Felig P. Very low calorie protein diets. N. Engl. J. Med. 310: 589, 1984.

    Article  PubMed  CAS  Google Scholar 

  30. Henry R.R., Gumbiner B. Benefits and limitations of very low-calorie diet therapy in obese NIDDM. Diabetes Care 14: 802, 1991.

    Article  PubMed  CAS  Google Scholar 

  31. Rotella CM., Cresci B., Mannucci E., Rizzello S.M., Colzi G., Galli G., Giannini S., Messeri G.; Piani F., Vannini R., Bucalossi A., Conti A., Serio M. Short cycles of very low calorie diet in the therapy of obese type II diabetes mellitus. J. Endocrinol. Invest. 17: 171, 1994.

    Article  PubMed  CAS  Google Scholar 

  32. Kramer F. M., Stalker L. A. Treatment of obesity. In: Freeman A., Simon K. M., Beutler L. E., Arkowitz H. (Eds.), Comprehensive handbook of cognitive therapy. Plenum Press, New York-London, 1989, p.385.

    Chapter  Google Scholar 

  33. Marlatt GA, Gordon J.R. Relapse prevention: Maintenance strategies in the treatment of addictive behaviors. Guilford Press, New York, 1985.

    Google Scholar 

  34. Bennet G.A. Cognitive-Behavioral treatments for obesity. J. Psychosom Res.32: 661, 1988.

    Article  Google Scholar 

  35. Fairburn CG., Marcus M.D., Wilson G.T. Cognitive-behaviuoral therapy for binge eating and bulimia nervosa: a comprehensive treatment manual. In: Fairburn CG., Wilson G.T. (Eds.), Binge Eating: nature, assessment and treatment. Guilford Press, New York-London, 1993, p. 361.

    Google Scholar 

  36. Brownell K.D., Kramer F.M. Behavioral management of obesity. In: Blackburn G.L., Kanders B.S. (Eds.), Obesity: Pathophysiology, Psychology and Treatment. Chapman & Hall, New York-London, 1994, p. 231.

    Google Scholar 

  37. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder, ed 4, Washington D.C, APA, 1994.

    Google Scholar 

  38. Spitzer R.L., Williams J.B.W., Gibbon M., First M.B. Structured Clinical Interview for DSM-III-R(SCID). American Psychiatric Press. Washington DC, 1990.

    Google Scholar 

  39. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039, 1979.

    Article  Google Scholar 

  40. Greist J.H., Jefferson J.W., Kobak KA, Chouinard G., DuBoff E., Halaris A., Kim S.W., Koran L, Leibowitz M.R., Lydiard B., McElroy S., Mendels J., Rasmussen S., White K., Flicker C. A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder. Int. Clin. Psychopharmacol. 10: 57, 1995.

    Article  PubMed  CAS  Google Scholar 

  41. Murdoch D., McTavish D. Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder. Drugs 44(4): 604, 1992.

    Article  PubMed  CAS  Google Scholar 

  42. Chouinard G., Goodman W., Greist J., Jenike M., Rasmussen S. Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. Psychopharmacol. Bull. 26: 279, 1990.

    PubMed  CAS  Google Scholar 

  43. Henderson M., Freeman C.P.L. A self-rating scale for bulimia: The Bite. Bri. J. Psychiatry 150: 18, 1987.

    Article  CAS  Google Scholar 

  44. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23, 56, 1960.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  45. Spielberg CD., Gorsuch R.L., Lushene R.E. Manual for the State-Trait Anxiety Inventory (self evaluation questionnaire). Consulting Psychologists Press, Paio Alto, 1970.

    Google Scholar 

  46. Murdoch D., McTavish D. Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder. Drugs 44: 605, 1992.

    Article  Google Scholar 

  47. Berkowitz R.I. Relapse Prevention in the Treatment of Obesity. In: Blackburn G.L., Kanders B.S. (Eds.), Obesity: Pathophysiology, Psychology and Treatment. Chapman & Hall, New York-London, 1994, p. 312.

    Google Scholar 

  48. Wilson G.T., Fairburn CG. Cognitive treatments for eating disorders. J. Consult. Clin. Psychol. 61: 261, 1993.

    Article  PubMed  CAS  Google Scholar 

  49. Collins R. L, Rothblum E. D., Wilson G. T. The comparative efficacy of cognitive and behavioral approaches to the treatment of obesity. Cognitive Ther. Res. 10: 299, 1986.

    Article  Google Scholar 

  50. Fairburn C. G., Cooper Z. New perspectives on dietary and behavioural treatments for obesity. Int. J. Obesity 20, S9, 1996.

    Google Scholar 

  51. Guy-Grand B., Apfelbaum M., Crepaldi G., Gries A., Lefebvre P. et al. International trial of long-term dexfenfluramine in obesity. Lancet 2:1142, 1989.

    Article  PubMed  CAS  Google Scholar 

  52. McTavish D., Heel R.C. Dexfenfluramine. A review of its pharmacological properties and therapeutic potential in obesity. Drugs 43: 713, 1992.

    Article  PubMed  CAS  Google Scholar 

  53. Bray G.A. Use and abuse of appetite-suppressant drugs in the treatment of obesity. Ann. Intern. Med. 119: 707, 1993.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Scienze Neurologiche e Psichiatriche, Unità Operativa di Psichiatria, Italy

    V. Ricca, M. Di Bernardo & R. L. Cabras

  2. Sezione di Malattie del Metabolismo e Diabetologia, Divisione di Endocrinologia, Dipartimento di Fisiopatologia Clinica e Istituto di Medicina Interna e Immunoallergologia, Università di Firenze, Viale Pieraccini 6, 50134, Firenze, Italy

    E. Mannucci, S. M. Rizzello &  C. M. Rotella

Authors
  1. V. Ricca
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Mannucci
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Di Bernardo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. M. Rizzello
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. L. Cabras
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. M. Rotella
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ricca, V., Mannucci, E., Di Bernardo, M. et al. Sertraline enhances the effects of cognitive-behavioral treatment on weight reduction of obese patients. J Endocrinol Invest 19, 727–733 (1996). https://doi.org/10.1007/BF03347875

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347875

Key-words

Search

Navigation